Investing in transformational ideas in Biotechnology and Technology; strategic, corporate venture capital fund of Merck KGaA investing in Healthcare drug development, Life Science tools, Electronics, and Frontier Technology & Sustainability.
| Firm name | M Ventures |
| Investment thesis/focus | Investing in transformational ideas in Biotechnology and Technology; strategic, corporate venture capital fund of Merck KGaA investing in Healthcare drug development, Life Science tools, Electronics, and Frontier Technology & Sustainability. |
| Headquarters location | Amsterdam, The Netherlands (Eduard van Beinumstraat 26, 1077 CZ Amsterdam) |
| Year founded | 2009 |
| Number of team members | 34 (including Managing Director Hakan Goker, CFO Caroline Soulard, directors, and associates) |
| Investment stage and check sizes | Corporate venture capital investing in visionary companies across Biotechnology and Technology; dual strategic and financial foci |
| Founding/Managing partners | Corporate venture fund of Merck KGaA, Darmstadt, Germany; Managing Director: Hakan Goker |
| Legal entity and parent | Strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany |
| Contact email | info@m-ventures.com |